4 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Points #EBM #Neuro #IM ... #Fremanezumab #Migraine ... #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Treatment of Chronic Migraine ... Points #EBM #Neuro #IM ... #Fremanezumab #Migraine ... #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Group #EBM #Neuro #IM ... #Fremanezumab #Migraine ... #CGRP #CalcitoninGeneRelatedPeptideAntibody ... AdverseEvents #NEJM ... #NEJM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
Romosozumab or Alendronate ... New Vertebral, Clinical ... PrimaryCare #Endo #IM ... #Romosozumab #Alendronate ... #NEJM